The invention relates to antibody coupling bismuth selenide nanometer particles for united treatment of tumor thermal treatment and immunotherapy and a preparation method of the antibody coupling bismuth selenide nanometer particles, and belongs to the field of a pharmaceutical preparation. According to the antibody coupling bismuth selenide nanometer particles, amination bismuth selenide is usedas a carrier, PEG is used as a cross-linking agent, and a CD47 resisting antibody is coupled to the surfaces of the nanometer particles. After an antibody coupling bismuth selenide nanometer particlesuspension is intravenously injected, the nanometer particles can be massively gathered to a tumor part in a targetted manner through an EPR effect, and the condition that drug administration of the CD47 resisting antibody to whole bodies of causes anemia, is avoided. Besides, the surface-modified CD47 resisting antibody and tumor cell surfaces are high-expressed CD47 molecule specific recognition, and CD47 and SIRP alpha signal channels are closed, so that macrophages anew obtain the capacity for swallowing tumor cells. Particularly, tumor cells are subjected to thermal treatment, the residual tumor cells are eliminated by the macrophages because a signal channel free from drug administration is closed, and the purpose of thoroughly eradicating rumors is realized. The method is reasonablein design, and simple in preparation technology, has broad application prospects, and lays a foundation for design and development of a corresponding drug administration system.